"A single large trial showed a benefit for vasomotor symptoms with the black cohosh Remifemin(r) (Enzymatic Therapy Inc., Green Bay Wisconsin) and is consistent with older German studies," the reviewers wrote, indicating that the remaining three studies showed no benefits from black cohosh. Results from two "were confounded by concurrent use of tamoxifen, known to exacerbate hot flashes," while another used a "more unusual (research) preparation, BN01055."

"Buyer beware" was the general conclusion of the Archives review, which clearly applies to black cohosh since recent studies have proven that not all black cohosh is the same. Most products in the market lack the standardization and research that can ensure efficacy and safety. An article in the Journal of Agricultural & Food Chemistry (2006;54(9):3242-53), reported that three of eleven black cohosh supplements purchased and tested in the United States did not even contain black cohosh (Actaea racemosa syn. Cimicifuga racemosa). Instead, the three contained less expensive extracts of Chinese cimicifuga (specific other Actaea spp.) that do not have all the same chemical compounds or clinical uses as the native North American plant. A fourth product indicated a probable mixture of the two plants.

Remifemin(r) comprises a proprietary, standardized extract (uniform dosage) of pure black cohosh root called RemiSure(tm). It is the most OB/GYN-recommended non-prescription menopause brand. The German E Commission has approved the use of 40 mg/day of black cohosh (Remifemin(r) brand) for 6 months for relief of menopausal symptoms, as well as for premenstrual syndrome (PMS) and dysmenorrhea.

"Remifemin(r) is clearly the world's most clinically tested black cohosh product," said Mark Blumenthal, Founder and Executive Director of the American Botanical Council. "Over 15 clinical trials demonstrate the safety and efficacy of the product, manufactured according to the latest GMPs by Shaper & Brummer GmbH, a highly respected German phytomedicine company with over 50 years of experience in manufacturing and testing Remifemin(r). Almost all of the scientific literature on black cohosh was conducted on Remifemin(r) including recent clinical trials showing no estrogenic activity of the product," he explained.

"Smart German chemists have been working on Remifemin(r) for over 50 years," said Yale University School of Medicine Clinical Professor Mary Jane Minkin, MD, who recommends Remifemin(r) as a standard alternative to HRT. "While its mechanism of action is unclear, black cohosh is one of the few products that seems to relieve hot flashes. I talk to everyone about Remifemin(r) along with lifestyle issues like healthy diet and exercise," she explained. "I respect the personal preferences of my patients, many of whom do not want drug intervention." Dr. Minkin is author of A Woman's Guide to Menopause & Perimenopause (Yale University Press 2005).

Overview of Recent Remifemin(r) Research
While the Archives' review limits itself only to studies published in the English language, numerous published studies from Europe demonstrate the efficacy and safety of the proprietary Remifemin(r) black cohosh formula. A summary of select research appears below.